Endurance Wealth Management’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $3K | Buy |
+300
| New | +$3K | ﹤0.01% | 570 |
|
|
2023
Q1 | – | Sell |
-300
| Closed | -$5K | – | 649 |
|
|
2022
Q4 | $5K | Hold |
300
| – | – | ﹤0.01% | 528 |
|
|
2022
Q3 | $7K | Hold |
300
| – | – | ﹤0.01% | 497 |
|
|
2022
Q2 | $5K | Hold |
300
| – | – | ﹤0.01% | 531 |
|
|
2022
Q1 | $8K | Hold |
300
| – | – | ﹤0.01% | 534 |
|
|
2021
Q4 | $8K | Hold |
300
| – | – | ﹤0.01% | 525 |
|
|
2021
Q3 | $28K | Hold |
300
| – | – | ﹤0.01% | 415 |
|
|
2021
Q2 | $20K | Hold |
300
| – | – | ﹤0.01% | 450 |
|
|
2021
Q1 | $23K | Hold |
300
| – | – | ﹤0.01% | 437 |
|
|
2020
Q4 | $26K | Sell |
300
-140
| -32% | -$12.1K | ﹤0.01% | 388 |
|
|
2020
Q3 | $32K | Hold |
440
| – | – | ﹤0.01% | 351 |
|
|
2020
Q2 | $32K | Buy |
+440
| New | +$32K | 0.01% | 353 |
|
|
2020
Q1 | – | Sell |
-650
| Closed | -$24K | – | 576 |
|
|
2019
Q4 | $24K | Buy |
+650
| New | +$24K | ﹤0.01% | 346 |
|